Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$17.78 - $42.39 $131,465 - $313,431
-7,394 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$47.84 - $64.34 $565,373 - $760,370
-11,818 Reduced 61.51%
7,394 $433,000
Q3 2021

Nov 12, 2021

BUY
$59.27 - $95.73 $919,574 - $1.49 Million
15,515 Added 419.66%
19,212 $1.14 Million
Q4 2020

Feb 12, 2021

BUY
$38.09 - $100.95 $140,818 - $373,212
3,697 New
3,697 $336,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $278M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Jasper Ridge Partners, L.P. Portfolio

Follow Jasper Ridge Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jasper Ridge Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Jasper Ridge Partners, L.P. with notifications on news.